184 related articles for article (PubMed ID: 19191749)
1. A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.
Kohn B; Grasberger H; Lam LL; Ferrara AM; Refetoff S
Thyroid; 2009 Feb; 19(2):187-91. PubMed ID: 19191749
[TBL] [Abstract][Full Text] [Related]
2. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
[TBL] [Abstract][Full Text] [Related]
3. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.
Aycan Z; Ağladıoğlu SY; Ceylaner S; Cetinkaya S; Baş VN; Kendirici HN
J Clin Res Pediatr Endocrinol; 2010; 2(4):168-72. PubMed ID: 21274318
[TBL] [Abstract][Full Text] [Related]
4. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
[TBL] [Abstract][Full Text] [Related]
5. A new silent germline mutation of the TSH receptor: coexpression in a hyperthyroid family member with a second activating somatic mutation.
Gozu HI; Mueller S; Bircan R; Krohn K; Ekinci G; Yavuzer D; Sargin H; Sargin M; Ones T; Gezen C; Orbay E; Cirakoglu B; Paschke R
Thyroid; 2008 May; 18(5):499-508. PubMed ID: 18466076
[TBL] [Abstract][Full Text] [Related]
6. Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.
Roberts SA; Moon JE; Dauber A; Smith JR
J Pediatr Endocrinol Metab; 2017 Mar; 30(3):343-347. PubMed ID: 28195550
[TBL] [Abstract][Full Text] [Related]
7. Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy.
Bertalan R; Sallai A; Sólyom J; Lotz G; Szabó I; Kovács B; Szabó E; Patócs A; Rácz K
Thyroid; 2010 Mar; 20(3):327-32. PubMed ID: 20146656
[TBL] [Abstract][Full Text] [Related]
8. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
Kopp P; Muirhead S; Jourdain N; Gu WX; Jameson JL; Rodd C
J Clin Invest; 1997 Sep; 100(6):1634-9. PubMed ID: 9294132
[TBL] [Abstract][Full Text] [Related]
9. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
Kosugi S
Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
[TBL] [Abstract][Full Text] [Related]
10. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.
Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M
Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847
[TBL] [Abstract][Full Text] [Related]
11. Persistent neonatal thyrotoxicosis in a neonate secondary to a rare thyroid-stimulating hormone receptor activating mutation: case report and literature review.
Watkins MG; Dejkhamron P; Huo J; Vazquez DM; Menon RK
Endocr Pract; 2008; 14(4):479-83. PubMed ID: 18558604
[TBL] [Abstract][Full Text] [Related]
12. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R).
Pohlenz J; Pfarr N; Krüger S; Hesse V
Acta Paediatr; 2006 Dec; 95(12):1685-7. PubMed ID: 17129985
[TBL] [Abstract][Full Text] [Related]
13. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
[TBL] [Abstract][Full Text] [Related]
14. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
[TBL] [Abstract][Full Text] [Related]
15. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
[TBL] [Abstract][Full Text] [Related]
16. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene.
Tonacchera M; Agretti P; Rosellini V; Ceccarini G; Perri A; Zampolli M; Longhi R; Larizza D; Pinchera A; Vitti P; Chiovato L
Thyroid; 2000 Oct; 10(10):859-63. PubMed ID: 11081252
[TBL] [Abstract][Full Text] [Related]
17. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
[TBL] [Abstract][Full Text] [Related]
18. A novel TSHR gene mutation (Ile691Phe) in a Chinese family causing autosomal dominant non-autoimmune hyperthyroidism.
Liu Z; Sun Y; Dong Q; He M; Cheng CHK; Fan F
J Hum Genet; 2008; 53(5):475-478. PubMed ID: 18306976
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.
Palos-Paz F; Perez-Guerra O; Cameselle-Teijeiro J; Rueda-Chimeno C; Barreiro-Morandeira F; Lado-Abeal J; ; Araujo Vilar D; Argueso R; Barca O; Botana M; Cabezas-Agrícola JM; Catalina P; Dominguez Gerpe L; Fernandez T; Mato A; Nuño A; Penin M; Victoria B
Eur J Endocrinol; 2008 Nov; 159(5):623-31. PubMed ID: 18694911
[TBL] [Abstract][Full Text] [Related]
20. [Activating mutations of the TSH receptor: a synthesis highlighting certain pediatric aspects].
Polak M
Arch Pediatr; 1998; 5 Suppl 4():375S-379S. PubMed ID: 9853087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
